טוען...
B cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia. The current treatment paradigm involves the use of chemoimmunotherapy, when patients develop an indication for therapy. With this strategy, a majority of patients will obtain a remission, though cure remains elusive. While treatab...
שמור ב:
| הוצא לאור ב: | Immunotargets Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918232/ https://ncbi.nlm.nih.gov/pubmed/27471698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S37419 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|